Pharma Products' Uncertain Path To Patient Assistance
The government and pharmaceutical manufacturers have taken opposing sides on an issue that pits the welfare of individual beneficiaries against the sustainability of the Medicare program as a whole....To view the full article, register now.
Already a subscriber? Click here to view full article